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j Abstract Background In the current debate about
the categorical or dimensional classification of mental
disorders many fruitful methods to illustrate one or
the other aspect are employed, and suggestions are
made to combine the two perspectives. Methods We
present such an approach to combine both perspec-
tives at the same time. Based on psychopathological
AMDP-symptom profiles, a map of psychiatric
patients was calculated by robust nonmetric multidi-
mensional scaling (NMDS). Results The sample
from the Ludwig-Maximilians University in Munich
included the records of patients, who were admitted
and discharged in 2002 and 2003 with a diagnosis of
either paranoid schizophrenia, (F20.00, N = 24),
bipolar affective disorder, current episode manic
without psychotic symptoms (F31.1, N = 32) or
severe depressive episode without psychotic symp-
toms (F32.2, N = 78). In the resulting map of patients
we found a clear categorical distinction according to
the diagnostic groups, but also high regression values
of AMDP-syndromes (manic syndrome: r = 0.83,
depressive syndrome: r = 0.68, and paranoid-hallu-
cinatory syndrome, r = 0.62). Discussion The map of
psychiatric patients presents an approach to consider
the categorical and dimensional aspects at the same
time. We were able to identify meaningful delinea-
tions between diagnostic clusters as well as continu-
ous transitions. This method allows the whole
psychopathological profile of each individual patient
to be considered and also to identify misdiagnosed
cases at a glance.
j Key words AMDP symptom-profiles Æ robust
nonmetric multidimensional scaling (NMDS) :
diagnosis Æ classification Æ categorical Æ dimensional
Introduction
How to characterize psychiatric patients has always
been a heavily debated issue. Over the last century,
the two classification systems, the diagnostic and
statistical manual (DSM) of the American Psychiatric
Association (APA) and the international classifica-
tion of diseases (ICD) of the World Health Organi-
zation (WHO), have been established as worldwide
standards in this regard. As we move towards the
revisions and new versions of these systems, DSM-V
and ICD-11, classificatory questions have again
become prominent in the research community. One
of the main challenges is the currently intensely
debated question of categorical or dimensional
diagnosis in psychiatry [10, 14, 22, 25, 29, 31, 43, 49].
A categorical diagnosis is achieved by defining the
membership of a subject (i.e. a patient) to a category
(i.e. a diagnosis) if a given number of diagnostic
criteria is met (the polythetic approach). A dimen-
sional diagnosis defines a cut-off point on a con-
tinuum of a given factor (i.e. a diagnosis of mental
retardation if a subject achieves an IQ of 70 or less).
In this debate, many fruitful methods supply both
the categorical and the dimensional perspective with
convincing lines of argument. To name just a few ofEA
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the more frequently employed methods, factor ana-
lytic and taxometric studies provide findings in
various diagnostic groups which speak in favor of a
dimensional view [14, 49]. However, findings sup-
porting a categorical view are also reported for
various groups of disorders e.g. [35, 48]. More recent
studies suggest on the whole that the two perspec-
tives are fundamentally equivalent [24], like two
sides of the same coin [41], and that both are useful
depending on the objectives [29, 31]. Consequently,
the focus of the question has shifted from whether it
is useful to integrate dimensional aspects to how
they can best be implemented in the existing, pre-
dominantly categorical, classification systems e.g.
[30, 36, 37, 44]. Hence, a method that is able to
combine the two perspectives presents an interesting
approach in this field of research. Such a method
was employed by our research group in an earlier
study [17], which considered both perspectives at the
same time by combining them within one analysis.
Using nonmetric multidimensional scaling (NMDS)
e.g. [8], we constructed a joint depiction of both
aspects. Based on the knowledge of experienced
psychiatrists and psychotherapists, we calculated an
expert model on the level of mental disorders
through NMDS, which was successfully validated in
a subsequent study [18]. With regard to current
classification questions, the map showed aspects of
concordance with the ICD-10 and the DSM-IV as
well as indicators supporting critical observations
made in this field. For instance, the difficulty of
delineating mood and anxiety disorders, which had
already been pointed out by Maser and Cloninger
[39] over 15 years ago, was well illustrated by the
spatial closeness of the corresponding diagnostic
clusters in the map. However, while this map pro-
vided interesting insights into the professionals’
perception of the mental disorders, it did not, of
course, allow any conclusions to be drawn about
how patients bearing the diagnoses are actually
related to each other. To attain this goal, real clinical
data are needed, which is the basis of current anal-
ysis of our research group. In a first step, we scaled
the 140 psychopathological AMDP [2] symptoms of
2,485 patients of the psychiatric hospital of the
Ludwig-Maximilians-University in Munich, exhibit-
ing the whole spectrum of mental disorders in a two-
dimensional NMDS space [34]. The AMDP rating
scale covers a broad spectrum of symptoms such as
delusions or disturbances of affect and is described
in more detail in the methods section. In the
resulting map, we were able to verify factors that had
been identified previously by factor analysis, and to
provide support for the stability of these factors over
time. Moreover, these results were complemented
with additional insights. For instance, the map of-
fered a plausible explanation as to why the apathy
syndrome [4], which had previously been assumed
clinically but had not been empirically identified,
could not have been found before. After establishing
such a map of psychopathological symptoms, we
now describe, in a second step, the construction of
a map containing patients. The positions of the
patients (i.e. the relational proximities) in the maps
are calculated based on the pairwise correlations of
their symptom profiles. Since such a map resulting
from a nonmetric multidimensional scaling consists
in a continuous Euclidian space, no categorical
decisions have to be made regarding a patient’s
membership of one categorical group or another.
Rather, the patient can be localized on a continuum.
Furthermore, patients can be mapped considering
the whole spectrum of psychopathological symptoms
without any prior data selection or weighting based
on a priori assumptions. The subsequent integration
of diagnostic data in the same map clarifies the
extent to which the patient exhibits an affiliation
with a given diagnostic category based on the
characteristics of the symptom profile, or whether
the patient stands between the categories, exhibiting
equally pronounced symptoms of multiple diagnostic
categories. Similar approaches were already being
pursued over 30 years ago. By combining several
multivariate methods of analysis and based on
symptom data, conceptual profiles of psychiatrists
regarding phenomenological subtypes were com-
pared to empirically derived profiles and were found
to correspond [40]. Another approach based on
symptom profiles originating in that period [50, 51]
is the grade of membership model, which is still
used today e.g. [16]. This approach has the impor-
tant advantage that patients can be characterized as
simultaneously and partially belonging to more than
one diagnostic class expressed by a weighted linear
combination of profiles of symptoms. This was
an important contribution to model a ‘‘continuum
of psychopathological symptoms where no clear
boundaries can be drawn and ‘entities’ are artificially
designated’’ [38]. The current study presents an
approach to build a continuous space of patients
based on their symptom characteristics. This allows
each case to be individually positioned and visual-
ized in relation to every other case without a priori
defining or empirically deriving categorical entities
or prototypes.
Methods
j Sample
The sample consists of patients who were hospitalized at the psy-
chiatric hospital of the Ludwig-Maximilians-University, Munich. It
included the records of patients who were admitted and discharged
between 1 January 2002 and 31 December 2003 with a diagnosis of
either paranoid schizophrenia (F20.00, N = 24), bipolar affective
disorder, current episode manic without psychotic symptoms
(F31.1, N = 32) or severe depressive episode without psychotic
symptoms (F32.2, N = 78). The diagnostic group of patients with
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severe depression was chosen since this entity by definition exhibits
the most depressive symptoms and can therefore be seen as pro-
totypical.
j Clinical data
In this study, the AMDP admission records were analyzed, which
are routinely collected one to four days after inpatient admission.
All included patients gave informed consent to be assessed using
this instrument. The AMDP system is an operationalized docu-
mentation system for psychopathology conceived for a broad
clinical use [6] and covering a large spectrum of 100 psychopath-
ological and 40 somatic symptoms. The symptom spectrum com-
prises disorders of consciousness, disturbances of attention and
memory, formal disorders of thought, phobias and compulsions,
delusions, disorders of perception, disorders of ego, disturbances of
affect, disorders of drive and psychomotility, circadian distur-
bances, other disturbances, disturbances of sleep and vigilance,
appetite disturbances, gastrointestinal disturbances, cardiac-respi-
ratory disturbances, other autonomic disturbances, and other
somatic disturbances. The AMDP originated from the translation of
the traditional psychopathology according to Jaspers [27], Schnei-
der [47], and others into a modern, standardized observer rating
scale, including operationalized criteria and definitions. It is the
most widely used and best known psychiatric documentation
system in the German-speaking area [35] and was developed by the
German-Swiss-Austrian ‘‘Association for Methodology and Docu-
mentation in Psychiatry’’ (Arbeitsgemeinschaft fu¨r Methodik und
Dokumentation in der Psychiatrie) [2]. Moreover, the AMDP sys-
tem has also been translated into many other languages [21], and
has been used in various international studies e.g. [12, 13, 26, 45,
46]. Reliability and validity is reported to be good to very good and
the AMDP can be considered a well established test based on a
multitude of empirical studies [3]. Symptom items are rated by
clinicians from 0 (symptom not present) to 1 (mild), 2 (moderate),
and 3 (severe). In this study, the psychopathological status
(symptoms 1–100) and the somatic status (symptoms 101–140)
were considered for further analysis.
j Statistical analyses
The maps of the patients were calculated by nonmetric multidi-
mensional scaling (NMDS) based on the AMDP symptom profiles.
First, the profiles between each pair of patients were converted into
a proximity coefficient. Since the nature of the data strongly
influences the choice of a coefficient [20], and based on our
experience stemming from the construction of the maps of the
symptoms [34], we evaluated difference and correlation measures
as proximity coefficients. While a difference measure more strongly
accounts for differences in the levels of symptom profiles (i.e. the
illness severity), the differences of the levels are less pronounced in
a correlation measure. For the present data, which are character-
ized mainly by qualitative differences (diagnostically different
groups), a Spearman correlation proved to be the most appropriate
coefficient. Due to the ranking of the data involved in a Spearman
correlation in combination with the specific data distributions of
the current sample (most observations are ‘‘0’’ = not present), this
coefficient visualizes qualitative differences more clearly than a
Pearson coefficient. The proximity coefficients were then translated
by the robust NMDS algorithm RobuScal [33] into a two-dimen-
sional space. NMDS iteratively approximates an n-dimensional
solution to maximally correspond to the given proximities on an
ordinal level. Hence, a small distance between two objects in an
NMDS space corresponds to a large similarity of these two objects
in the proximity matrix and vice versa. A scree test can be em-
ployed to identify the optimal compromise between a minimal
dimensionality and a maximal congruence between the similarities
given by the proximity matrix and the distances given by the
configuration in the n-dimensional space. To integrate the
dimensional expression of the severity in the maps, the AMDP sum
scores were calculated for every patient in total and separately for
each syndrome identified by Baumann and Stieglitz [4]. These
external scales were then fitted using multiple regressions e.g. [8]
into the NMDS maps. All statistics were computed using SPSS for
Windows, Microsoft Excel and ProDaX.
Results
A scree test [11], adopted for multidimensional scal-
ing by Kruskal and Wish [32], showed no substantial
diminution of the standardized stress values in higher
than two-dimensional spaces, which is why the
two-dimensional solution was chosen. The stress
value is a measure that expresses the extent of the
misrepresentations of the proximities in relation to
their representations as distances depicted in the
n-dimensional NMDS solution. This solution, i.e. the
map of the patients, is presented in Fig. 1. According
to the literature [8] and the more conservative limits
of our own research group, the stress value of 0.22
speaks for a good interpretability of the map. The
cases diagnosed with schizophrenia (F20.00) are
depicted as black circles, the cases diagnosed with
bipolar affective disorder, current episode manic
without psychotic symptoms (F31.1) as white squares
and the cases diagnosed with severe depressive epi-
sode without psychotic symptoms (F32.2) as grey
squares. The closer two representations of patients are
(i.e. circles or squares), the more similar their
symptomatology, i.e. the larger the covariance of their
symptom profiles, which was expressed as a high
Spearman correlation coefficient. The diagnoses were
matched with the cases only after the map was cal-
culated based on the symptom profiles. In the map,
three major clusters are evident: One ‘‘depressive’’
cluster in the upper left corner, one ‘‘manic’’ cluster in
the upper right corner and one less clearly separated
‘‘schizophrenic’’ cluster at the bottom middle. Some
cases can be observed as lying between or at the
borders of the clusters, such as F32.2_112 and
F32.2_120 at the border of the depressive and oriented
towards the manic cluster, F31.1_29 and F31.1_41
between the manic and schizophrenic clusters, or
F20.00_9 and F32.2_80 between the schizophrenic and
depressive clusters. Furthermore, some cases seem to
be misplaced and emerge in clusters where they do
not seem to belong: the manic cases F31.1_31 and
F31.1_55 and the schizophrenic cases F20.00_8,
F20.00_12, F20.00_20, and F20.00_22 in the depressive
cluster, the depressive case F32.2_96 in the manic
cluster and the depressive case F32.2_86 in the
schizophrenic cluster. Some of these cases lying at
the intersections and in the ‘‘wrong’’ clusters are
described and interpreted in detail as examples in the
discussion section. To clarify which symptoms were
associated with which diagnostic entity, the ICD-10
criteria for research [15] were consulted: Based on the
diagnostic criteria, the corresponding AMDP symp-
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toms were determined. This resulted in a group of
symptoms that were associated with schizophrenia, a
group of symptoms that were associated with
depression, and a group of symptoms that were
associated with mania. Hence, it was possible to ex-
press for each patient the percentage of symptoms
actually exhibited in relation to all potentially ob-
servable symptoms within a diagnostic entity (e.g. a
given schizo-manic case might exhibit 50% schizo-
phrenic, 50% manic, and 0% depressive symptoms).
Of course, this approach is a simplification, since
there are symptoms that can be attributed to more
than one diagnostic entity at the same time. Here,
only the symptoms that could be attributed unam-
biguously to a diagnostic entity were considered.
It should be mentioned in this regard that the pro-
cedure mainly served as a rough indication of the
appropriateness of the position of the patients in the
map based on their symptom characteristics in rela-
tion to the diagnostic clusters.
In Fig. 2, the same patient map is presented as in
Fig. 1, but this time including the AMDP symptom
score dimensions. Since they were fitted into the map
by multiple regressions, the expectations for the
regression values were higher, which is why only the
dimensions exhibiting an r ‡ 0.60 are depicted in
the map. Consequently, three dimensions are shown,
the dimension based on the AMDP sum scores for the
manic syndrome (MA, r = 0.83), the dimension based
on the AMDP sum scores for the depressive syndrome
Fig. 1 Map of patients including the cases diagnosed with schizophrenia
(F20.00 black circles), bipolar affective disorder, current episode manic without
psychotic symptoms (F31.1 white squares) and severe depressive episode with-
out psychotic symptoms (F32.2 grey squares). Stress value = 0.22. The labels
next to the dots and squares, representing the positions of the patients, denote
the ICD-10 diagnostic F-codes (before the underscore) and the patient IDs (after
the underscore)
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(DE, r = 0.68), and the dimension based on the AMDP
sum scores for the paranoid-hallucinatory syndrome
(PH, r = 0.62). The closer an orthogonal projection of a
patient is located on a given dimension, the larger the
sum score of this patient on the corresponding AMDP
syndrome scale. The dimensions intersect in the center
of gravity of the configuration.
Discussion
Figure 1 depicts the map of the patients, which was
calculated based on the similarity of their AMDP
symptom profiles. At first glance, it is evident that the
map is constituted by three main cluster structures. In
the upper right corner, the mania cluster is the one
that is most clearly separated from the other two
clusters. The depression cluster in the upper left is
still quite clearly confined, but shows a clearer ten-
dency to scatter in the direction of the schizophrenia
cluster, which is located at the bottom middle. This
cluster can still be identified as being separate from
the other two, but shows a strong tendency to blend
with the depression cluster. Looking at the arrange-
ment of the diagnostic clusters, it has to be kept in
mind that the map was calculated based only on the
correlations of the symptom profiles without any
diagnostic information. Only after the positions of the
cases had been determined were the diagnoses ap-
plied. Against this background, it can be concluded
that these three diagnostic entities can be clearly
separated from each other only based on their psy-
chopathological symptomatology. The separation of
the depressive and the manic cluster given by their
positions at the opposed poles of the affective con-
tinuum e.g. [23] is clearly reflected in this map. The
gap without any cases between these clusters indicates
that although the diagnostic entities lie on a contin-
uum, the cases lying at the poles can be separated
from each other in a categorical sense. It can be ex-
pected that the continuum would have emerged more
prominently if we would have chosen patients with a
diagnosis of bipolar disorder with hypomanic epi-
sodes instead of manic episodes cf. [5]. Blashfield [7]
had already mentioned that clearly delimited clusters
and zones of rarity between the clusters can be
interpreted as an indicator for a categorical classifi-
cation and vice versa. In light of this statement, the
depressive and schizophrenic clusters do not seem to
be as clearly separated from each other as the
depressive and manic clusters. In the former case, no
clear-cut gap between the clusters can be observed.
The area between the depressive and the schizo-
phrenic clusters could indeed be described as a ‘‘zone
Fig. 2 Identical map of patients to
Fig. 1, additionally including the
symptom score dimensions (MA
manic syndrome, r = 0.83; DE
depressive syndrome, r = 0.68; PH
paranoid-hallucinatory syndrome,
r = 0.62)
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of rarity’’, but there are a number of cases that are
located in the intersection. Such observations are
reflected in the research literature as findings
reporting that these diagnostic categories cannot be
separated neatly [28], that no substantial discontinu-
ity was apparent [42], or even that a separate
depressive dimension could be identified in schizo-
phrenic patients [9]. A closer look at the cases in the
schizophrenic-depressive intersection reveals that
these patients exhibit pronounced depressive as well
as schizophrenic symptoms. For instance, the
depressive case F32.2_80 exhibits 57% depressive
symptoms of the total symptom score obtained on
either depressive, schizophrenic or manic symptoms,
and 24% schizophrenic symptoms (and 19% manic
symptoms). Case F20.00_9 exhibits 54% schizo-
phrenic, 36% depressive and 11% manic symptoms.
Of course, the covariance of other symptoms not in-
cluded in these three groups (manic, depressive,
schizophrenic) also contributed to the position of
these cases. Nevertheless, this examination of the
percentage sum scores illustrates that although these
patients show a prevalence of their symptoms in the
diagnostic entities in which they are diagnosed, they
also exhibit a significant amount of symptoms of the
other diagnostic entity, which is well reflected in their
position between the diagnostic clusters in the map.
Another illustrative example to highlight this obser-
vation is case F32.2_112, with 50% depressive and
50% manic symptoms, which is located at the border
of the depressive cluster oriented towards the manic
cluster. The cases F20.00_12, F31.1_31 and F32.2_96
illustrate that their position within another diagnostic
cluster is not so ‘‘wrong’’ if one takes a closer look at
their symptom profile. F20.00_12 exhibits 89%
depressive and only 11% schizophrenic symptoms,
F31.1_31 exhibits 72% depressive, 11% schizophrenic
and 17% manic symptoms, and case F32.2_96 exhibits
6% depressive, 78% manic and 17% schizophrenic
symptoms. It is evident that based on the symptom
characteristics these cases are not misplaced but are
rather misdiagnosed (at least with regard to the pre-
dominant symptomatology). A cross-check with the
patient charts corroborated this conclusion. These few
singled-out examples clarify some of the main
advantages of these maps: In the continuous NMDS
maps, cases can be located in differentiated distances
to each other and do not have to be separated into one
categorical pigeonhole or another, where no in-
between exists. This shortcoming of the current
classification systems is one of the reasons why an
increasing number of diagnostic categories keep
being introduced. In turn, this results (among other
consequences) in the prominent problem of numer-
ous diagnostic co-occurrences, i.e. comorbid diagno-
ses [19, 24]. The integration of the categorical and
the dimensional perspective by depicting categorical
aspects as separated clusters in a continuous or
dimensional space allows a statement to be made about
the membership of a given patient to a diagnostic entity,
without sacrificing the illustration of a variable strength
of association with multiple entities. This is quite sim-
ilar to a grade of membership approach, where the grade
of membership score describes the degree of an indi-
vidual’s belonging to an empirically derived prototype.
Also similar to this approach, if there is a substantial
number of patients exhibiting a similar symptom
profile, an NMDS allows new (not a priori specified)
diagnostic entities to be discovered (such a diagnostic
entity would emerge in a map as a ‘‘neighborhood’’ of
patients exhibiting a similar symptom profile).
The possibility of interpreting the positions of
specific cases lying at the boarders of diagnostic
clusters or in between clusters with regard to their
symptom characteristics already highlights the power
of this method in terms of dimensional aspects. This
advantage is even more pronounced by the integration
of the syndrome dimensions in the map of the patients
presented in Fig. 2. All AMDP syndromes (paranoid-
hallucinatory, depressive, psychoorganic, manic,
hostility, autonomic, apathy, obsessive-compulsive,
neurological) identified by Baumann and Stieglitz [4]
were included in the multiple regressions, but only the
ones with an r ‡ 0.60 were depicted in the map. As one
would expect, especially the three dimensions based
on the symptom scores of the manic, the depressive,
and the paranoid-hallucinatory syndromes showed
such substantially high regression values in this map
of manic, depressive and schizophrenic patients. The
directions of the dimensions indicate that cases with a
more severe, i.e. a higher, symptom score of a syn-
drome are located in the clusters of the corresponding
diagnostic categories. The larger an angle between two
given dimensions, the more independent the dimen-
sions are from each other. Keeping this in mind, the
above-mentioned stronger separation of the manic
cluster from the other two clusters becomes apparent
again. The rather acute angle between the depressive
and the paranoid-hallucinatory dimensions, i.e. syn-
dromes, indicates that these syndromes are not inde-
pendent with regard to the diagnostic groups of
patients with depression and schizophrenia.
As indicated in the introduction, current research
on the classification of the mental disorders calls for
methods that facilitate the integration of dimensional
aspects in classification systems in general [30, 37, 44]
and in the field of mood and psychotic disorders in
particular [42]. Taking together the arguments men-
tioned above, the method presented here might offer
an interesting perspective for such integration. An-
other advantage of this robust approach can be seen in
the ability to consider the whole spectrum of symp-
toms without having to rely on a priori assumptions
in terms of reducing or weighing any symptoms.
Thus, the whole symptomatology of a patient can be
included and the relations to all other cases in the
sample can be analyzed and depicted. In the resulting
map, every patient can be located and is not lost within
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a group score of a sub-sample. As demonstrated
above, this allows misdiagnoses in terms of symp-
tomatology to be identified at just one glance.
This paper illustrated a method to depict patients
in a map according to the similarity of their psycho-
pathological symptom profiles and highlighted some
of the advantages of such an approach. Of course, the
localization of the patients is restricted to their
symptomatology, but since clinical symptoms con-
stitute a predominant proportion of the criteria of the
major current classification systems, these maps
might be of considerable value for researchers as well
as clinicians in order to gain a quick overview of their
patients. The focus on the symptomatology and the
depiction of the individuals in relation to each other
can also be seen as a step in the direction of the re-
cently claimed re-emphasis [1] on phenomenological
aspects and the singularity of an individual patient.
The presented study is the first of its kind, so limi-
tations are to be seen in the following aspects: Based on
the current selection of diagnostic groups and without
further research, we can not be sure that the separation
will achieve comparable optimal results in other diag-
nostic areas. Additionally, the AMDP does not differ-
entiate at the same level of detail in all areas of
psychopathology. Therefore, this statistical analysis
should also be applied to other diagnostic rating scales.
Finally, the validity of the data set is strongly depend-
ing on the quality of the clinical ratings. The latter
aspect sounds trivial but has to be taken into account:
Especially when time resources are limited and hours
spent for diagnosis are not available for treatment any
longer, ways are to be found to improve the motivation
for sound and correct application of diagnostic man-
uals. Immediate feedback of the diagnosis resulting
from the just performed manual could be intuitively
provided by maps like the one presented in this paper,
simply by adding a point for the current patient at the
resulting position. Such immediate feedback could
help to improve data quality and, at the same time,
support the diagnostic process. However, as men-
tioned above, this would require a system of maps
covering all fields of psychopathology so that the pre-
sented study can only be seen as the first and initial step
towards an ‘‘AMDP based atlas of mental disorders’’.
j Acknowledgments This study was supported by a grant from
the Swiss National Science Foundation (fellowship, project no.
117011).
References
1. Andreasen NC (2007) DSM and the death of phenomenology in
America: an example of unintended consequences. Schizophr
Bull 33:108–112
2. Arbeitsgemeinschaft fu¨r Methodik und Dokumentation in der
Psychiatrie (1981) Das AMDP-System. Manual zur Dokumen-
tation psychiatrischer Befunde. Springer, Berlin
3. Baumann U, Stieglitz RD (1997) Das AMDP-system: ein psy-
chologischer test? In: Haug H-J, Stieglitz RD (Hrsg.) Das
AMDP-system in der klinischen Anwendung und Forschung.
Hogrefe, Go¨ttingen, S 30–45
4. Baumann U, Stieglitz RD (1983) Testmanual zum AMDP-Sys-
tem: Empirische Studien zur Psychopathologie. Springer, Berlin
5. Benazzi F (2006) The continuum/spectrum concept of mood
disorders: is mixed depression the basic link? Eur Arch Psy-
chiatry Clin Neurosci 256:512–515
6. Berner P (1983) Diagnostic classification based on the AMDP-
system. In: Bobon D, Baumann U, Angst J, Helmchen H,
Hippius H (eds) The AMDP-system in pharmacopsychiatry.
Karger, Basel, pp 68–73
7. Blashfield RK (1990) Comorbidity and classification. In: Maser
JD, Cloninger CR (eds) Comorbidity of mood and anxiety
disorders. American Psychiatric Press, Washington, DC, pp 61–
82
8. Borg I, Groenen P (2005) Modern multidimensional scal-
ing—theory and applications. Springer, New York
9. Bottlender R, Strauss A, Mo¨ller HJ (2000) Prevalence and
background factors of depression in first admitted schizo-
phrenic patients. Acta Psychiatr Scand 101:153–160
10. Brown TA, Barlow DH (2005) Dimensional versus categorical
classification of mental disorders in the fifth edition of the
diagnostic and statistical manual of mental disorders and be-
yond: comment on the special section. J Abnorm Psychol
114:551–556
11. Cattell RB (1966) The scree test for the number of factors.
Multivariate Behav Res 1:245–276
12. Cuesta MJ, Peralta V (2001) Integrating psychopathological
dimensions in functional psychoses: a hierarchical approach.
Schizophr Res 52:215–229
13. Cuesta MJ, Peralta V, Zarzuela A (2000) Reappraising insight in
psychosis: multi-scale longitudinal study. Br J Psychiatry
177:233–240
14. De Boeck P, Wilson M, Acton GS (2005) A conceptual and
psychometric framework for distinguishing categories and
dimensions. Psychol Rev 112:129–158
15. Dilling H, Mombour W, Schmidt MH, Schulte-Markwort E
(2004) Internationale Klassifikation psychischer Sto¨rungen
ICD-10 Kapitel V (F) Diagnostische Kriterien fu¨r Forschung
und Praxis. World Health Organization, Genf
16. Dragovic M, Hammond G, Badcock JC, Jablensky A (2005)
Laterality phenotypes in patients with schizophrenia, their
siblings and controls: associations with clinical and cognitive
variables. Br J Psychiatry 187:221–228
17. Egli S, Schlatter K, Streule R, La¨ge D (2006) A structure-based
expert model of the ICD-10 mental disorders. Psychopathology
39:1–9
18. Egli S, Streule R, La¨ge D (2008) The structure-based expert
model of the mental disorders: a validation study. Psycho-
pathology 41:286–293
19. First MB (2005) Mutually exclusive versus co-occurring diag-
nostic categories: the challenge of diagnostic comorbidity.
Psychopathology 38:206–210
20. Gower JC, Legendre P (1986) Metric and euclidean properties of
dissimilarity coefficients. J Classif 3:5–48
21. Guy GW, Ban TA (1982) The AMDP system: manual for the
assessment and documentation of psychopathology. Springer,
Berlin
22. Haslam N (2003) Categorical versus dimensional models of
mental disorder: the taxometric evidence. Aust NZ J Psychiatry
37:696–704
23. Haug HJ, Ahrens B (2002) Affektive Sto¨rungen. In: Freyberger
HJ, Schneider W, Stieglitz R-D (Hrsg.) Kompendium Psychi-
atrie, Psychotherapie, psychosomatische Medizin. Karger,
Basel, S 100–118
24. Jablensky A (2005) Boundaries of mental disorders. Curr Opin
Psychiatry 18:653–658
25. Jablensky A (2005) Categories, dimensions and prototypes:
critical issues for psychiatric classification. Psychopathology
38:201–205
170
26. Ja¨ger M, Bottlender R, Strauss A, Mo¨ller HJ (2004) Fifteen-year
follow-up of ICD-10 schizoaffective disorders compared with
schizophrenia and affective disorders. Acta Psychiatr Scand
109:30–37
27. Jaspers K (1997) General psychopathology (1913). Johns Hop-
kins University Press, Baltimore
28. Kempf L, Hussain N, Potash JB (2005) Mood disorder with
psychotic features, schizoaffective disorder, and schizophrenia
with mood features: trouble at the borders. Int Rev Psychiatry
17:9–19
29. Kendell R, Jablensky A (2003) Distinguishing between the
validity and utility of psychiatric diagnoses. Am J Psychiatry
160:4–12
30. Kraemer HC (2007) DSM categories and dimensions in clinical
and research contexts. Int J Methods Psychiatr Res 16:S8–S15
31. Kraemer HC, Noda A, O’Hara R (2004) Categorical versus
dimensional approaches to diagnosis: methodological chal-
lenges. J Psychiatr Res 38:17–25
32. Kruskal JB, Wish M (1978) Multidimensional scaling. Sage
Publications, Beverly Hills
33. La¨ge D, Daub S, Bosia L, Ja¨ger C, Ryf S (2005). Die Behandlung
ausreißerbehafteter Datensa¨tze in der Nonmetrischen Multidi-
mensionalen Skalierung—Relevanz, Problemanalyse und
Lo¨sungsvorschlag (Forschungsberichte aus der Angewandten
Kognitionspsychologie Nr. 21). Universita¨t Zu¨rich, Psycholog-
isches Institut
34. La¨ge D, Egli S, Mo¨ller HJ, Strauss A, Riedel M (2008) Exploring
the structure of psychopathological symptoms—a re-analysis
of AMDP data by robust nonmetric multidimensional scaling.
Manuscript submitted for publication
35. Lauterbach E, Rumpf HJ, Ahrens B, Haug HJ, Schaub R,
Schonell H, Stieglitz RD, Hohagen F (2005) Assessing dimen-
sional and categorical aspects of depression: validation of the
AMDP depression scale. Eur Arch Psychiatry Clin Neurosci
255:15–19
36. Lecrubier Y (2008) Refinement of diagnosis and disease clas-
sification in psychiatry. Eur Arch Psychiatry Clin Neurosci
258(Suppl 1):6–11
37. Lopez MF, Compton WM, Grant BF, Breiling JP (2007)
Dimensional approaches in diagnostic classification: a critical
appraisal. Int J Methods Psychiatr Res 16(Suppl 1):S6–S7
38. Manton KG, Korten A, Woodbury MA, Anker M, Jablensky A
(1994) Symptom profiles of psychiatric disorders based on
graded disease classes: an illustration using data from the
WHO international pilot study of schizophrenia. Psychol Med
24:133–144
39. Maser JD, Cloninger CR (1990) Comorbidity of anxiety and
mood disorders: introduction and overview. In: Maser JD,
Cloninger CR (eds) Comorbidity of mood and anxiety disor-
ders. American Psychiatric Press, Washington, DC, pp 3–12
40. Overall JE, Woodward JA (1975) Conceptual validity of a
phenomenological classification of psychiatric patients. J Psy-
chiatr Res 12:215–230
41. Peralta V, Cuesta MJ (2007) A dimensional and categorical
architecture for the classification of psychotic disorders. World
Psychiatry 6:36–37
42. Peralta V, Cuesta MJ (2007) Exploring the borders of the
schizoaffective spectrum: a categorical and dimensional
approach. J Affect Disord (in press)
43. Pickles A, Angold A (2003) Natural categories or fundamental
dimensions: on carving nature at the joints and the rearticu-
lation of psychopathology. Dev Psychopathol 15:529–551
44. Regier DA (2007) Dimensional approaches to psychiatric clas-
sification: refining the research agenda for DSM-V: an intro-
duction. Int J Methods Psychiatr Res 16:S1–S5
45. Salvatore P, Khalsa HMK, Hennen J, Tohen M, Yurgelun-Todd
D, Casolari F, DePanfilis C, Maggini C, Baldessarini RJ (2007)
Psychopathology factors in first-episode affective and non-
affective psychotic disorders. J Psychiatr Res 41:724–736
46. Sato T, Bottlender R, Kleindienst N, Mo¨ller HJ (2002) Syn-
dromes and phenomenological subtypes underlying acute
mania: a factor analytic study of 576 manic patients. Am J
Psychiatry 159:968–974
47. Schneider K (1959) Clinical psychopathology. Grune and
Stratton, New York
48. Watson D (2005) Rethinking the mood and anxiety disorders: a
quantitative hierarchical model for DSM-V. J Abnorm Psychol
114:522–536
49. Widiger TA, Samuel DB (2005) Diagnostic categories or
dimensions? A question for the diagnostic and statistical
manual of mental disorders—fifth edition. J Abnorm Psychol
114:494–504
50. Woodbury MA, Clive J, Garson A Jr (1978) Mathematical
typology: a grade of membership technique for obtaining dis-
ease definition. Comput Biomed Res 11:277–298
51. Woodbury MA, Manton KG (1982) A new procedure for
analysis of medical classification. Methods Inf Med 21:210–220
171
